Therapy-related orbital myeloid sarcoma is very rare (1) . A 61-year-old woman was admitted because of protrusion of the right eyeball (Picture 1). Computed tomography revealed a mass lesion in the right orbit that showed the uptake of 18 F-fluorodeoxyglucose on positron emission tomography (Picture 2). A biopsy of the right orbit mass revealed proliferation of atypical cells that were positive for myeloperoxidase (Picture 3). A bone marrow examination showed neither an increase in blasts nor myelodysplasia. A diagnosis of myeloid sarcoma confined to the right orbit was made. She had a history of ovarian carcinoma treated with irinotecan and cisplatin 10 years earlier, so her disease was classified Intern Med 58: 1045-1046, 2019 DOI: 10.2169/internalmedicine.2105-18 as therapy-related myeloid neoplasm (2) . She received remission-induction chemotherapy for acute myeloid leukemia (idarubicin plus cytarabine) followed by a consolidation radiotherapy toward the right orbit. After the treatment, the protrusion of the right eyeball was markedly improved (Picture 4).
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